CymaBay Therapeutics, Inc.
0I5P.L
Price:
$32.4836
Market Cap:
$3.73B
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of primary biliary cholangitis (PBC), as well as has completed Phase 2b clinical study to treat patients with nonalcoholic steatohepatitis. The company also develops MBX-2982, which is in Phase 2a clinical study for the disease/condition of hypoglycemia in type 1 diabetics. It has a license agreement with ABW Cyclops SPV LP to support development of seladel...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2018-01-29
Stock Exchange
LSE
Ticker
0I5P.L
PE Ratio
[-24.55]
ROE
[-64.17%]
Current Ratio
[10.96]
Dividend Yield
[0%]
Enterprise Value
[3.64B]
Dividend History
The ROE as of July 2025 (TTM) for CymaBay Therapeutics, Inc. (0I5P.L) is -64.17%
According to CymaBay Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -64.17%. This represents a change of 333.99% compared to the average of -14.79% of the last 4 quarters.
CymaBay Therapeutics, Inc. (0I5P.L) Historical ROE (quarterly & annually)
How has 0I5P.L ROE performed in the past?
The mean historical ROE of CymaBay Therapeutics, Inc. over the last ten years is -156.16%. The current -64.17% ROE has changed -58.91% with respect to the historical average. Over the past ten years (40 quarters), 0I5P.L's ROE was at its highest in in the June 2023 quarter at -0.75%. The ROE was at its lowest in in the June 2017 quarter at -417.44%.
Average
-156.16%
Median
-55.05%
Minimum
-677.44%
Maximum
-32.44%
CymaBay Therapeutics, Inc. (0I5P.L) ROE by Quarter and Year
Discovering the peaks and valleys of CymaBay Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.13%
Maximum Annual ROE = -32.44%
Minimum Annual Increase = -95.21%
Minimum Annual ROE = -677.44%
| Year | ROE | Change |
|---|---|---|
| 2023 | -36.05% | -89.04% |
| 2022 | -328.85% | 372.19% |
| 2021 | -69.64% | 104.22% |
| 2020 | -34.10% | -37.84% |
| 2019 | -54.86% | 28.88% |
| 2018 | -42.57% | 31.23% |
| 2017 | -32.44% | -95.21% |
| 2016 | -677.44% | 1.13% |
| 2015 | -55.23% | -76.03% |
| 2014 | -230.45% | 325.43% |
CymaBay Therapeutics, Inc. (0I5P.L) Average ROE
How has 0I5P.L ROE performed in the past?
The current ROE of CymaBay Therapeutics, Inc. (0I5P.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-144.85%
5-year avg
-104.70%
10-year avg
-156.16%
CymaBay Therapeutics, Inc. (0I5P.L) ROE vs. Peers
How is 0I5P.L’s ROE compared to its peers?
CymaBay Therapeutics, Inc.’s ROE is less than Nationwide Building Society (12.68%), less than musicMagpie plc (0%), greater than Great Portland Estates Plc (-63.67%), less than Schroder Investment Trust - Schroder AsiaPacific Fund plc (5.90%), less than null (14.36%),
| Company | ROE | Market cap |
|---|---|---|
| 12.68% | $1.38B | |
| 0% | $8.83M | |
| -63.67% | $1.35B | |
| 5.90% | $782.31M | |
| 14.36% | $0 |
Build a custom stock screener for CymaBay Therapeutics, Inc. (0I5P.L) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CymaBay Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
CymaBay Therapeutics, Inc. (0I5P.L) and other stocks custom spreadsheet templates
The easiest way to analyze a company like CymaBay Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is CymaBay Therapeutics, Inc.'s ROE?
How is the ROE calculated for CymaBay Therapeutics, Inc. (0I5P.L)?
What is the highest ROE for CymaBay Therapeutics, Inc. (0I5P.L)?
What is the 3-year average ROE for CymaBay Therapeutics, Inc. (0I5P.L)?
What is the 5-year average ROE for CymaBay Therapeutics, Inc. (0I5P.L)?
How does the current ROE for CymaBay Therapeutics, Inc. (0I5P.L) compare to its historical average?